Dr. Mark Boguski, M.D., Ph.D, Chief Medical Officer
Mark Boguski M.D., Ph.D is the Chief Medical Officer of Liberty Biosecurity LLC.
Previously, Dr. Boguski served on the faculties of Harvard Medical School and Beth Israel Deaconess Medical Center where he founded the Genomic Medicine Initiative in 2009. He has held faculty positions at the Johns Hopkins University School of Medicine, the Fred Hutchinson Cancer Research Center and the U.S. National Institutes of Health. Dr. Boguski also served as Vice President of the Novartis Institute for Biomedical Research and as the founding Director of the Paul Allen Institute for Brain Science.
Dr. Boguski is a pioneer in the fields of Bioinformatics, Genomics and Precision Medicine and has been an adviser to numerous medical research organizations including the Merck Genome Research Institute, the Genetics Advisory Group for the Welcome Trust and the Howard Hughes Medical Institute.
Dr. Boguski received the Regents' Award from the National Library of Medicine and the Director's Award from the National Institutes of Health. He is an elected member of the National Academy of Medicine, an honorary Fellow of the College of American Pathologists, a Fellow of the American College of Medical Informatics, a former reviewing editor for Science magazine and past Editor-in-Chief of Genomics.
He is a graduate of the Medical Scientist Training Program at Washington University in St. Louis.
Publications
Podcasts
Honors and Awards
Previously, Dr. Boguski served on the faculties of Harvard Medical School and Beth Israel Deaconess Medical Center where he founded the Genomic Medicine Initiative in 2009. He has held faculty positions at the Johns Hopkins University School of Medicine, the Fred Hutchinson Cancer Research Center and the U.S. National Institutes of Health. Dr. Boguski also served as Vice President of the Novartis Institute for Biomedical Research and as the founding Director of the Paul Allen Institute for Brain Science.
Dr. Boguski is a pioneer in the fields of Bioinformatics, Genomics and Precision Medicine and has been an adviser to numerous medical research organizations including the Merck Genome Research Institute, the Genetics Advisory Group for the Welcome Trust and the Howard Hughes Medical Institute.
Dr. Boguski received the Regents' Award from the National Library of Medicine and the Director's Award from the National Institutes of Health. He is an elected member of the National Academy of Medicine, an honorary Fellow of the College of American Pathologists, a Fellow of the American College of Medical Informatics, a former reviewing editor for Science magazine and past Editor-in-Chief of Genomics.
He is a graduate of the Medical Scientist Training Program at Washington University in St. Louis.
Publications
- Bioinformatics - Link
- ESTablishing a human transcript map - Link
- Functional Genomics: It's All How You Read It - Link
Podcasts
- Mark Boguski on Antidotes to Overspecialization - Link
Honors and Awards
- Gerty T. Cori Predoctoral Fellowship and Prize, Washington University, Division of Biology and Biomedical Sciences and Sigma Chemical Company, 1985.
- Regents Award from the National Library of Medicine for "Scholarly and Technical Contributions to the Construction of the Human Transcript Map." October 24, 1996.
- NIH Director's Award for contributions to the "NCI Tumor Gene Index Project." June 25, 1998. (Harold Varmus was Director at the time.)
- One of the Inaugural "All-Stars" (in the fields of Bioinformatics and Gene Expression), elected by the readers of Genome Technology magazine, July 2001.
- Fellow of the American Medical Informatics Association (AMIA). Elected October 1, 2001.
- Member of the U.S. National Academy of Medicine (NAM). Elected October 1, 2001.
- "Pioneer of Proteomics" U.S. National Cancer Institute. August 2006.
- "Visionary and Influencer" The Personalized Medicine Coalition. August 2006.
- Novartis VIVA (Vision, Innovation, Value, Achievement) Award; Team Innovation Award; Global Information Technology Innovation Award, 2006 and 2007
- Fellow of the College of American Pathologists, 2010.